Dalfampridine 10 mg/1 (Dalfampridine TABLET, FILM COATED, EXTENDED RELEASE) 10 mg/1

Dalfampridine 10 mg tablets are an extended-release medication used to improve walking in adults with multiple sclerosis (MS). This prescription drug is designed to enhance mobility and is available in a convenient film-coated tablet form.

Strength

10 mg/1

Pack Size

60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0591-2533-60)

Manufacturer / TM Owner

Actavis Pharma, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Dalfampridine is primarily used to improve walking in adults diagnosed with multiple sclerosis (MS). This medication is designed to enhance mobility and may help with walking speed and endurance. It is important to consult a healthcare provider to determine if Dalfampridine is suitable for your specific condition.

Side Effects

Common effects of Dalfampridine may include dizziness, nausea, and headaches. Some users may experience insomnia or blurred vision. It is essential to monitor any adverse reactions and consult a healthcare professional if they persist or worsen.

Precautions & Warnings

Dalfampridine should be used with caution, especially in individuals with a history of seizures or kidney problems. It is important to follow the prescribed dosage and avoid exceeding the recommended amount. Always inform your healthcare provider about any other medications you are taking.

Avoid Interactions

Dalfampridine may interact with other medications, including those that affect the central nervous system. It is crucial to avoid alcohol while taking this medication, as it can increase the risk of side effects. Always consult a healthcare provider before starting or stopping any medication.

Frequently Asked Questions

Dalfampridine is used to improve walking in adults with multiple sclerosis (MS). It is designed to enhance mobility and may help with walking speed and endurance.

Dalfampridine is available in extended-release tablets and should be taken orally as prescribed by a healthcare provider. It is important to follow the recommended dosage and administration instructions.

Common side effects of Dalfampridine may include dizziness, nausea, headaches, insomnia, and blurred vision. If these effects persist or worsen, consult a healthcare professional.

Dalfampridine may interact with other medications, especially those that affect the central nervous system. Always consult a healthcare provider before combining Dalfampridine with other drugs.

Dalfampridine should be used with caution, particularly in individuals with a history of seizures or kidney problems. It is important to discuss your medical history with a healthcare provider before starting Dalfampridine.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.